Megan E. Cavanaugh
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
Papers in
- Oncology 4
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 2
- Peptidase Inhibition and Analysis 1
-
- Head and Neck Cancer Studies 1
- Co-authors
- Neil H. Hyman (1 shared paper)Turner M. Osler (1 shared paper)Patrick Hall Lizotte (4 shared papers)Nicole Grace Chau (2 shared papers)Jonathan Daniel Schoenfeld (2 shared papers)Ravindra Uppaluri (2 shared papers)Jochen H. Lorch (2 shared papers)Glenn J. Hanna (2 shared papers)
- Journals
- Diseases of the Colon & Rectum (1 paper)Cancer Discovery (1 paper)Developmental Dynamics (1 paper)Cancer Immunology Research (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesTaiwanNetherlands
In The Last Decade
Megan E. Cavanaugh
10 papers receiving 1.2k citations
Megan E. Cavanaugh's Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 749
- Otorhinolaryngology 90
- Pulmonary and Respiratory Medicine 395
- Immunology 263
- Cancer Research 130
Countries citing papers authored by Megan E. Cavanaugh
This map shows the geographic impact of Megan E. Cavanaugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan E. Cavanaugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan E. Cavanaugh more than expected).
Fields of papers citing papers by Megan E. Cavanaugh
This network shows the impact of papers produced by Megan E. Cavanaugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan E. Cavanaugh. The network helps show where Megan E. Cavanaugh may publish in the future.
Co-authors
The 25 scholars most cited alongside Megan E. Cavanaugh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation Hit paper breakdown → | 2017 | 619 |
| 2 | 2018 | 226 | |
| 3 | 2002 | 91 | |
| 4 | 2021 | 89 | |
| 5 | 2018 | 77 | |
| 6 | 2017 | 45 | |
| 7 | 2021 | 38 | |
| 8 | 2010 | 34 | |
| 9 | 2021 | 23 | |
| 10 | 1999 | 18 |
About Megan E. Cavanaugh
Megan E. Cavanaugh is a scholar working on Oncology, Otorhinolaryngology, Biotechnology, Molecular Biology and Immunology, having authored 10 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), CAR-T cell therapy research (2 papers), Peptidase Inhibition and Analysis (1 paper), Advanced Breast Cancer Therapies (1 paper), Cancer Research and Treatments (1 paper), Pluripotent Stem Cells Research (1 paper), Head and Neck Cancer Studies (1 paper) and Nanopore and Nanochannel Transport Studies (1 paper). The work is most often cited by research in Oncology (749 citations), Otorhinolaryngology (90 citations), Pulmonary and Respiratory Medicine (395 citations), Immunology (263 citations) and Cancer Research (130 citations). Megan E. Cavanaugh has collaborated with scholars based in United States, Taiwan and Netherlands. Frequent co-authors include Neil H. Hyman, Turner M. Osler, Patrick Hall Lizotte, Nicole Grace Chau, Jonathan Daniel Schoenfeld, Ravindra Uppaluri, Jochen H. Lorch, Glenn J. Hanna, Robert I. Haddad and Priyanka Shivdasani. Their work appears in journals such as Diseases of the Colon & Rectum, Cancer Discovery, Developmental Dynamics, Cancer Immunology Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.